Feb 9 (Reuters) – Shield Therapeutics PLC: * SHIELD THERAPEUTICS – FDA GRANTS ADDITIONAL EXCLUSIVITY FOR ACCRUFER * SHIELD THERAPEUTICS : EXCLUSIVITY REMAINS IN PLACE UNTIL 19 DEC 2028 IN ADDITION TO ACCRUFER/FERACCRU PATENT COVERAGE VALID UNTIL MID-2030S Source text: Further company coverage: ;))
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
New Delhi [India], May 16: Gujarat-based director producer Chanda Patel once again brought Indian elegance…
Noida (Uttar Pradesh) [India], May 16: Somerville International School, Noida successfully organised the fourth edition…
New Delhi [India], May 16: As Indian students increasingly explore diverse academic and career pathways…
The Afghanistan Cricket Board has formally requested the BCCI to stage their upcoming three-match T20I…
New Delhi [India], May 15: Xazina, the New Delhi-based lab-grown diamond jewellery design label, is…
Mumbai (Maharashtra) [India], May 15: As India rapidly moves toward a digitally connected future, the…